Gimv launches life sciences investment platform
Listed investor Gimv is carving out its life sciences portfolio into a new platform that will give it the firepower to deploy bigger tickets and increase the size of its portfolio, the firm tells Unquote.
More on GPs
IPO offers CVC chance to become multi-asset consolidator
Potential IPO also offers monetisation solution for founders and GP stakes investor Blue Owl
VC Profile: Possible Ventures lines up frontier tech deals halfway through fresh EUR 60m fundraise
Germany-based pre-seed investor is set to hold a first close for its third fund in mid-September
GP Profile: Apheon builds on family roots, mulls exits and reinvestment opportunities
Belgian GP, formerly known as Ergon, to continue to target family- and entrepreneur-owned European businesses
Kudu to step up boutique GP stake deals in Europe
MassMutual-backed investor aims to add more infrastructure and specialised equity GPs to its portfolio
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds